Literature DB >> 26026718

SDF-1/CXCR4 promotes F5M2 osteosarcoma cell migration by activating the Wnt/β-catenin signaling pathway.

Yao Lu1, Bin Hu, Guo-Feng Guan, Jie Chen, Chun-qiu Wang, Qiong Ma, Yan-Hua Wen, Xiu-Chun Qiu, Xiao-ping Zhang, Yong Zhou.   

Abstract

Osteosarcoma (OS), the most common primary malignant bone tumor in children and adolescents, lacks an effective therapy. Stromal cell-derived factor (SDF-1) and its receptor, CXCR4, play multiple roles in migration, proliferation, and survival of different tumor cells. This study aimed to investigate whether the functional SDF-1/CXCR4 signaling mediates chemotaxis in F5M2 OS cells as well as the underlying mechanisms. Immunohistochemistry and immunofluorescence microscopy were used. RNA expression was detected by real-time quantitative polymerase chain reaction, and protein expression was examined by Western blotting. Migration assays were carried out in F5M2 cells. The results showed that the expression of CXCR4 and β-catenin mRNA and protein was significantly higher in OS tissues compared to the surrounding non-neoplastic tissues. SDF-1 promoted F5M2 cell migration by activating the AKT and Wnt/β-catenin signaling pathway, which was abrogated by preincubation with AMD3100 and LY294002. In conclusion, SDF-1/CXCR4 axis-promoted F5M2 cell migration was regulated by the Wnt/β-catenin signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26026718     DOI: 10.1007/s12032-015-0576-0

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  34 in total

1.  SDF-1/CXCR4 promotes epithelial-mesenchymal transition and progression of colorectal cancer by activation of the Wnt/β-catenin signaling pathway.

Authors:  Ting-Hua Hu; Yu Yao; Shuo Yu; Li-Li Han; Wen-Juan Wang; Hui Guo; Tao Tian; Zhi-Pin Ruan; Xiao-Min Kang; Jing Wang; Shu-Hong Wang; Ke-Jun Nan
Journal:  Cancer Lett       Date:  2014-08-20       Impact factor: 8.679

2.  Osteosarcoma in adolescents and young adults: new developments and controversies. Commentary on the use of presurgical chemotherapy.

Authors:  M P Link
Journal:  Cancer Treat Res       Date:  1993

3.  MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer.

Authors:  William Kong; Lili He; Marc Coppola; Jianping Guo; Nicole N Esposito; Domenico Coppola; Jin Q Cheng
Journal:  J Biol Chem       Date:  2010-04-06       Impact factor: 5.157

Review 4.  Current treatment of osteosarcoma.

Authors:  W S Ferguson; A M Goorin
Journal:  Cancer Invest       Date:  2001       Impact factor: 2.176

5.  Combined Wnt/β-catenin, Met, and CXCL12/CXCR4 signals characterize basal breast cancer and predict disease outcome.

Authors:  Jane D Holland; Balázs Györffy; Regina Vogel; Klaus Eckert; Giovanni Valenti; Liang Fang; Philipp Lohneis; Sefer Elezkurtaj; Ulrike Ziebold; Walter Birchmeier
Journal:  Cell Rep       Date:  2013-11-27       Impact factor: 9.423

6.  Stromal cell-derived factor-1/CXCR4 enhanced motility of human osteosarcoma cells involves MEK1/2, ERK and NF-kappaB-dependent pathways.

Authors:  Chun-Yin Huang; Chun-Yi Lee; Meng-Yi Chen; Wei-Hung Yang; Ying-Hao Chen; Chia-Hao Chang; Horng-Chaung Hsu; Yi-Chin Fong; Chih-Hsin Tang
Journal:  J Cell Physiol       Date:  2009-10       Impact factor: 6.384

Review 7.  Wnt pathway and breast cancer.

Authors:  Sonia Mohinta; Hailong Wu; Priyasri Chaurasia; Kounosuke Watabe
Journal:  Front Biosci       Date:  2007-05-01

8.  Breast cancer metastasis: demonstration that FOXP3 regulates CXCR4 expression and the response to CXCL12.

Authors:  Stephen Douglass; Annette P Meeson; Dorota Overbeck-Zubrzycka; John G Brain; Miriam R Bennett; Christopher A Lamb; Thomas W J Lennard; David Browell; Simi Ali; John A Kirby
Journal:  J Pathol       Date:  2014-07-09       Impact factor: 7.996

9.  Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program.

Authors:  Lisa Mirabello; Rebecca J Troisi; Sharon A Savage
Journal:  Cancer       Date:  2009-04-01       Impact factor: 6.860

10.  Preclinical development of a novel class of CXCR4 antagonist impairing solid tumors growth and metastases.

Authors:  Luigi Portella; Rosamaria Vitale; Stefania De Luca; Crescenzo D'Alterio; Caterina Ieranò; Maria Napolitano; Anna Riccio; Maria Neve Polimeno; Luca Monfregola; Antonio Barbieri; Antonio Luciano; Andrea Ciarmiello; Claudio Arra; Giuseppe Castello; Pietro Amodeo; Stefania Scala
Journal:  PLoS One       Date:  2013-09-13       Impact factor: 3.240

View more
  6 in total

1.  Long noncoding RNA FGFR3-AS1 promotes osteosarcoma growth through regulating its natural antisense transcript FGFR3.

Authors:  Jiabing Sun; Xuming Wang; Chunjiang Fu; Xiaoyu Wang; Jilong Zou; Hanbing Hua; Zhenggang Bi
Journal:  Mol Biol Rep       Date:  2016-03-29       Impact factor: 2.316

2.  Clinical Significance of Cancer Stem Cell Markers CD133 and CXCR4 in Osteosarcomas.

Authors:  Azam Mardani; Elmira Gheytanchi; Seyed Hamzeh Mousavie; Zahra Madjd Jabari; Tina Shooshtarizadeh
Journal:  Asian Pac J Cancer Prev       Date:  2020-01-01

3.  Role of the stromal cell derived factor-1 in the biological functions of endothelial progenitor cells and its underlying mechanisms.

Authors:  Yanping Cun; Bo Diao; Zhimin Zhang; Gang Wang; Jing Yu; Lianting Ma; Zhiguo Rao
Journal:  Exp Ther Med       Date:  2020-11-17       Impact factor: 2.447

4.  Identification of potential gene signatures associated with osteosarcoma by integrated bioinformatics analysis.

Authors:  Yutao Jia; Yang Liu; Zhihua Han; Rong Tian
Journal:  PeerJ       Date:  2021-05-27       Impact factor: 2.984

5.  Single cell RNA sequencing of AML initiating cells reveals RNA-based evolution during disease progression.

Authors:  L C Stetson; Dheepa Balasubramanian; Susan Pereira Ribeiro; Tammy Stefan; Kalpana Gupta; Xuan Xu; Slim Fourati; Anne Roe; Zachary Jackson; Robert Schauner; Ashish Sharma; Banumathi Tamilselvan; Samuel Li; Marcos de Lima; Tae Hyun Hwang; Robert Balderas; Yogen Saunthararajah; Jaroslaw Maciejewski; Thomas LaFramboise; Jill S Barnholtz-Sloan; Rafick-Pierre Sekaly; David N Wald
Journal:  Leukemia       Date:  2021-07-09       Impact factor: 12.883

6.  To Explore the Mechanism of the GRM4 Gene in Osteosarcoma by RNA Sequencing and Bioinformatics Approach.

Authors:  Yunguo Pang; Jinmin Zhao; Mitra Fowdur; Yun Liu; Hao Wu; Maolin He
Journal:  Med Sci Monit Basic Res       Date:  2018-01-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.